Dr. Reddy’s Labs Q4 results: Net profit increased by 76% to Rs 764 crores
Dr. Reddy’s Labs Q4 results: It is one of the largest multinational pharmaceutical companies in India located in Hyderabad. The company founded by Anji Reddy, who works as Indian drugs and pharmaceuticals limited. The company manufactures and markets different pharmaceuticals in India. However, the company manufactures almost 190 medications, 60 APIs for drugs, diagnostic kits, and biotechnology products.
Meanwhile, on Wednesday, May 20, the company reported its Q4 results for the Financial Year 2020. The company’s consolidated net profit increased by 75.92% to Rs 764.2 crores Year-on-Year in the quarter ended in March. The company also posted its standalone profit of Rs 434.4 crores in the same quarter last financial year.
Besides, the total revenue of the company increased by almost 10% to Rs 4,432 crores ended in March. While the companies EBITDA margin increased by 22.6% compared to the previous year. Whereas, the profit after tax (PAT) margin increased by 17.2% as against 10.8% in the same quarter last year.
“However, this quarter is positive to the companies growth. The company programs during this year include VAi status for CTO 6, healthy product pipeline build-up, productivity improvement, and strong financial performance of the company across our business”, said GV Prasad, Co-Chairman and MD, Dr. Reddy’s Labs.
On the other side, the company reported the highest market in North America with almost Rs 1,807.2 crores of revenue. While Europe region contributes almost Rs 3446 crores and India contributes Rs 6,839 crores. Whereas, the emerging markets of the company contribute almost Rs 8,042 crores. Besides, the companies R&D’s expenditure increased by 9.5% as against 9.1% in the same quarter last year.

On Wednesday, May 20, the shares of Dr. Reddy’s Labs Ltd reported a bullish trend in the stock market. The company gained 215.45 points with a 5.82% increase and reached 3,915.05 INR. While in BSE, the company gained 211.20 points with a 5.71% increase and reached 3,910.75 INR.
Stock Market on May 20:
On Wednesday, both Sensex and Nifty continues its bullish trend in the stock market on Wednesday. The Sensex is trading above 30,800 levels, and Nifty is trading above 8,900 levels in the stock market. The Sensex gained 622.44 points with a 2.06% increase and reached a 30,818.61 level. While Nifty gained 187.45 points with a 2.11% increase and reached 9,066.55 level.
On the other side, the number of coronavirus cases in India reached 1,06,750 as of Wednesday, May 20, and deaths reached 3,303.
In the border market, the S&P BSE Smallcap index reported a bullish trend in the stock market on Wednesday. It gained 117.19 points with a 1.13% increase and reached a 10,472.37 level. The S&P BSE Midcap index gained 166.09 points with a 1.49% increase and reached an 11,278.22 level. While Nifty Bank gained 353.95 with a 2.02% increase and reached a 17,840.20 level.
Top Gainers on May 20: Shree Cements, M&M, Dr. Reddy’s Labs, HDFC, and Eicher Motors are the top gainers in today’s stock market
Top Losers on May 20: Bharti Infratel, Indusind Bank, Hero Motocorp, Vedanta, and Bharti Airtel are the top losers in today’s stock market.
